Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-016930

Director acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fust Matthew K Director 2022-03-04 Option exercise +7,500 $40.37 $302,775 23,195 D
Derivatives
Fust Matthew K Director 2022-03-04 Option exercise · Stock Option (Right to Buy) −7,500 0 D
Loading xslF345X03/doc4.xml…